Search clinical trials for: Fludarabine (FLU)

Total 3380 results

Gruppo Italiano Trapianto di Midollo Osseo

Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis (GITMO-MF2010)

Myelofibrosis

Italy
University Hospital Inselspital, Berne
University of Lausanne; University of Bern

Completed

Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes (CARBEX1)

Hypoglycemia | Exercise | Type 1 Diabetes Mellitus | Carbohydrate Metabolism

Switzerland
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay

Respiratory Disease

United Kingdom
Glycostem Therapeutics BV

Recruiting

Registry of Patients Having Received oNKord®

AML

Switzerland, Germany
Glycostem Therapeutics BV

Recruiting

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Belgium, Netherlands, Switzerland, France, Germany
PepTcell Limited

Completed

Phase 1b Influenza Vaccine Study in Healthy Subjects

Influenza

United Kingdom
GlaxoSmithKline

Recruiting

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Influenza, Human

United States
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Unknown

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Acute Myeloid Leukemia | Elderly | Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning

China
EDAN Instruments Inc.
MDx CRO (MED IVD HEALTHTECH S.L.)

Recruiting

Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection

SARS-CoV2 Infection | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

Spain
Groupe Hospitalier Paris Saint Joseph

Completed

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

Influenza

France
Sekisui Diagnostics, LLC
Beaufort CRO

Unknown

Assessment of the Clinical Performance of the ARROW-FLU System

Influenza, Human

United States
Sekisui Diagnostics, LLC

Completed

Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B

Influenza, Human

United States
University of Southern California

Withdrawn

Fasting-mimicking Diet and Immunosenescence

Immunosenescence
University of California, San Francisco
American Cancer Society, Inc.; Kaiser Permanente

Completed

FLU-FIT Program at Kaiser Permanente Northern California

Colorectal Cancer Screening

United States
Ellume Pty Ltd

Completed

Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B

Influenza A | Influenza B

Australia
University of California, San Francisco
Centers for Disease Control and Prevention; San Francisco Department of Public...

Completed

The FLU-FOBT Program in Primary Care Settings Where Disparities Persist

Colorectal Cancer

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Influenza, Human

United States
Tatyana Zubkova

Completed

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Respiratory Syncytial Virus Infections

Russian Federation
Green Cross Corporation

Completed

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

Prevention of Influenza
National Institute of Arthritis and Musculoskeletal...

Completed

A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

Psoriasis | Arthritis, Psoriatic

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia

Neutropenia | Pancytopenia | Aplastic Anemia | Severe Aplastic Anemia

United States
PepTcell Limited
Norwegian Institute of Public Health; University Medical Center Groningen; University... and other collaborators

Completed

A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

Influenza

Netherlands
Thermo Fisher Scientific, Inc

Active, not recruiting

Project STARFISH - PRJ0002679 (STARFISH)

SARS-CoV-2 Infection | Influenza A | RSV Infection | Influenza Type B

United States
Lucira Health Inc

Completed

Performance Evaluation of the Lucira COVID-19 & Flu Test

COVID-19 | Influenza

United States
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults

Influenza

Sweden
University of Lausanne Hospitals

Completed

Rapid Flu Tests in Travelers With Fever

Influenza

Switzerland
The Jackson Laboratory
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Recruiting

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults (FluVax3)

Aging | Influenza Vaccine | Vaccine Response | Dendritic Cell

United States
University of Texas at Austin

Unknown

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

Depression | Healthy

United States
Nantes University Hospital
Cyceron

Not yet recruiting

Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients (Myelofludate)

Myeloma

France
University Hospital Birmingham
Ortho Biotech, Inc.; Gambro Renal Products, Inc.

Completed

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy (EuLITE)

Multiple Myeloma | Kidney Failure | Cast Nephropathy

United Kingdom
Naoyuki G. Saito, M.D., Ph.D.

Withdrawn

A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myeloid Leukemia | Acute Lymphocytic Leukemia

United States
GlaxoSmithKline

Active, not recruiting

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Influenza, Human

United States
Green Cross Corporation

Completed

A Multicenter, Double-blind, Parallel Phase III Study

Influenza

Korea, Republic of
Peking University People's Hospital
The University of Science and Technology of China

Unknown

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Ellume Pty Ltd

Completed

Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction

Influenza

Australia
Emory University

Completed

Sickle Cell Disease Conditioning for Bone Marrow Transplant

Sickle Cell Disease | Bone Marrow Transplantation

United States
Hebei Senlang Biotechnology Inc., Ltd.

Recruiting

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Health Sciences North Research Institute
NOAMA NORTHERN ONTARIO ACADEMIC MEDICINE ASSOCIATION

Unknown

Protection From Influenza: Determining the Impact of Prior Infection

Influenza

Canada
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Recruiting

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Myelodysplastic Syndrome | Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning

China
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Corona Virus Infection | Immunity | Flu Vaccine

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Influenza Vaccine | Cost-Benefit Analysis

Italy
University Hospital, Basel, Switzerland

Recruiting

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection (TARGET III)

Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)

Switzerland
University of California, Los Angeles

Recruiting

Effects of Prompt to Bundle COVID-19 Booster and Flu Shot

COVID-19 | Vaccines

United States
Ellume Pty Ltd

Completed

Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.

Influenza

Australia
National Institute of Arthritis and Musculoskeletal...

Completed

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Systemic Lupus Erythematosus | Glomerulonephritis | Lupus Nephritis

United States
Roswell Park Cancer Institute

Completed

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
Aptitude Medical Systems
Biomedical Advanced Research and Development Authority

Recruiting

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

SARS-CoV-2 Infection | Influenza A | Influenza B

United States
DiaSorin Molecular LLC

Not yet recruiting

LIAISON NES Flu A/B & COVID-19 Clinical Agreement

Coronavirus Disease 2019 | Influenza A | Influenza Type B

Australia
Abbott Rapid Diagnostics Jena GmbH

Completed

Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel

COVID-19 | Influenza A | Influenza Type B

United States
University Hospital, Caen
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France

Completed

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies (FLUDATEP)

Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients

France

Search clinical trials for: Fludarabine (FLU)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations